title: Βones, stones and androgen deprivation therapy.
authors.affiliation: Urology Department, La Inmaculada Hospital, Huércal-Overa, Almería, Spain.
authors.forename: Miguel Ángel
authors.initials: MÁ
authors.lastname: Arrabal-Polo
authors.affiliation: Urology Department, La Inmaculada Hospital, Huércal-Overa, Almería, Spain.
authors.forename: María Del Carmen
authors.initials: Mdel C
authors.lastname: Cano-García
authors.affiliation: Urology Department, University Hospital of Granada, Institute IBS Granada, Granada; Spain.
authors.forename: Miguel
authors.initials: M
authors.lastname: Arrabal-Martín
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects; D001851:Bone Diseases, Metabolic / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control; D001842:Bone and Bones / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D053040:Nephrolithiasis / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D012008:Recurrence; D012307:Risk Factors
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D050071:Bone Density Conservation Agents